← Eichor
Condition: Hepatitis Delta Virus Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Hepatitis Delta Virus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear S
Phase 3 · 1 location(s) · Huahui Health · NCT07499544Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus Infection
Phase N/A · 3 location(s) · Tam Anh Research Institute · NCT06638320Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Phase 2/Phase 3 · 35 location(s) · Mirum Pharmaceuticals, Inc. · NCT07454837Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Phase 1/Phase 2 · 19 location(s) · Gilead Sciences · NCT07096193Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrho
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06397859Standardising Care for Hepatitis Delta in the Netherlands
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT05903742Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D
Phase N/A · 2 location(s) · Research Center of Periodontal-Systemic Interactions · NCT07491848HDV Screening Study
Phase N/A · 1 location(s) · Grace Lai Hung Wong · NCT06889805Thailand HDV Cohort
Phase N/A · 4 location(s) · The HIV Netherlands Australia Thailand Research Collaboratio · NCT05350865National Cohort of Patients Co-infected With Hepatitis B and Delta Viruses
Phase N/A · 38 location(s) · ANRS, Emerging Infectious Diseases · NCT04166266Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With Bulvertide
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07429864Find HDV and Determine Its Status in Turkey
Phase N/A · 2 location(s) · Yaşar Bayındır, MD · NCT06248580DELTA DESCRIBE: the French Collaborative Project
Phase N/A · 1 location(s) · University Hospital, Limoges · NCT05936073A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)
Phase 3 · 48 location(s) · Mirum Pharmaceuticals, Inc. · NCT07200908Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients
Phase N/A · 1 location(s) · Karolinska University Hospital · NCT06051045"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chron
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04690972Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chr
Phase 1 · 2 location(s) · Aarhus University Hospital · NCT07610772"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.
Phase N/A · 1 location(s) · FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · NCT07317011Evaluation of Patients With Liver Disease
Phase N/A · 1 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT00001971D-SOLVE Cohorts (Cohort a and B)
Phase N/A · 4 location(s) · Hannover Medical School · NCT06160635Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bule
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06504485Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT06122285
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.